Graypoint LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.76M | Buy |
16,386
+1,371
| +9% | +$147K | 0.1% | 148 |
|
2025
Q1 | $1.51M | Buy |
15,015
+118
| +0.8% | +$11.9K | 0.09% | 149 |
|
2024
Q4 | $1.33M | Buy |
14,897
+550
| +4% | +$49.1K | 0.08% | 154 |
|
2024
Q3 | $1.2M | Buy |
14,347
+1,046
| +8% | +$87.7K | 0.08% | 172 |
|
2024
Q2 | $1.02M | Buy |
13,301
+663
| +5% | +$51.1K | 0.07% | 174 |
|
2024
Q1 | $866K | Buy |
12,638
+541
| +4% | +$37.1K | 0.06% | 192 |
|
2023
Q4 | $699K | Buy |
12,097
+6,349
| +110% | +$367K | 0.06% | 206 |
|
2023
Q3 | $303K | Sell |
5,748
-2,576
| -31% | -$136K | 0.03% | 332 |
|
2023
Q2 | $450K | Buy |
8,324
+2,925
| +54% | +$158K | 0.04% | 238 |
|
2023
Q1 | $270K | Buy |
+5,399
| New | +$270K | 0.03% | 296 |
|